Pharmaceutical - Financial, Global

Filter

Current filters:

FinancialGlobal

Popular Filters

1 to 25 of 30 results

EXPERT VIEW: How can pharmaceutical companies adapt to the digital era?

EXPERT VIEW: How can pharmaceutical companies adapt to the digital era?

06-08-2014

‘Digital pharma’ is by no means a new concept for pharmaceutical marketers. But what is new is that…

FinancialGlobalMarkets & MarketingPharmaceutical

Private equity firms could be looking to acquire mature GSK and Sanofi brands

Private equity firms could be looking to acquire mature GSK and Sanofi brands

05-08-2014

Private equity groups KKR and Warburg Pincus are considering a $10 billion plan to buy drug brands from…

Business FinanceFinancialGlaxoSmithKlineGlobalMylanPharmaceuticalSanofi

Pharma more optimistic about future despite upcoming industry consolidation

Pharma more optimistic about future despite upcoming industry consolidation

13-06-2014

More than 69% of senior players within the pan-world pharma industry expect to see a year-on-year increase…

FinancialGlobalMergers & AcquisitionsPharmaceutical

Report shows rise in IPOs revive investments in pharma and biotech

Report shows rise in IPOs revive investments in pharma and biotech

29-05-2014

The heightened private equity and venture capital (PEVC) deal activity in the global health care industry…

BiotechnologyBusiness FinanceFinancialGlobalHealth Medical PharmaPharmaceuticalPharmaceutical industryPharmaceutical sciencesPrivate

Report: R&D market is diversifying innovation, with increased partnerships, mergers and revenue sharing models

06-03-2014

The R&D sector is set to grow at more than 8% driven by new evaluation techniques, according to CPhI…

FinancialGlobalPharmaceuticalResearch

New schizophrenia drug Abilify to lead the market by 2016

New schizophrenia drug Abilify to lead the market by 2016

29-12-2013

Long-acting depot therapy Abilify Maintena (aripiprazole) will become the leading injectable schizophrenia…

AbilifyAbilify MaintenaFinancialGlobalLundbeckMarkets & MarketingNeurologicalOtsukaPharmaceutical

Report: Alzheimer’s Disease market to reach $3.8 billion in 2019

Report: Alzheimer’s Disease market to reach $3.8 billion in 2019

27-12-2013

The Alzheimer’s Disease (AD) market will increase slightly from $3.6 billion in 2012 to $3.8 billion…

FinancialGlobalMarkets & MarketingNeurologicalPharmaceuticalResearch

What will 2014 hold for pharma?

What will 2014 hold for pharma?

20-12-2013

We take a look at key trends for 2014.

FinancialGlobalMarkets & MarketingPharmaceutical

Lack understanding of the impact of global drug pricing on profits, finds Model N survey

10-12-2013

More than half (58%) of pharmaceutical companies believe the challenges of global drug pricing are not…

FinancialGlobalPharmaceuticalPricing

Health spending down in a third of OECD nations, as governments cut budgets

21-11-2013

Total health spending has fallen in one of three Organization for Economic Cooperation and Development…

FinancialGlobalHealthcarePharmaceutical

Baxter buys exclusive rights to CTI’s cancer drug pacritinib

18-11-2013

USA-based companies Baxter International and Cell Therapeutics have entered into an exclusive worldwide…

Baxter InternationalCell TherapeuticsFinancialGlobalLicensingOncologypacritinibPharmaceutical

Current profitability is a priority for 80% of pharma companies ahead of future

04-11-2013

Pharmaceutical companies are more concerned with getting their existing business right, before implementing…

FinancialGlobalPharmaceuticalResearch

Growing diabetes market will attract superior disease control

29-08-2013

The expected rise in diabetes is encouraging pharma companies to race to launch type 2 diabetes drugs,…

DiabetesFinancialGlobalPharmaceutical

Multiple sclerosis market could reach $18.3 billion in 2018

19-08-2013

The multiple sclerosis (MS) market is expected to peak at $18.3 billion in 2018, according to healthcare…

AubagioBiogen IdecFinancialGilenyaGlobalNovartisPharmaceuticalSanofiTecfidera

Rx drugs bulk buying may save governments money but poses a risk for some patients, says Canadian think-tank

14-05-2013

Governments that opt for prescription drug bulk-purchasing agreements can save taxpayers money but at…

FinancialGlobalHealthcarePharmaceutical

Europe falling behind USA and China as attractive for life sciences sector

22-04-2013

Intellectual property specialists Marks & Clerk's latest Life Sciences Report unveils the changing landscape…

BiotechnologyFinancialGlobalPatentsPharmaceuticalRegulationResearch

Revenue growth optimism in pharmaceutical industry: 2013 surveys report

20-02-2013

According to new global pharmaceutical industry surveys on buyer spend and procurement strategies, 55%…

FinancialGlobalMarkets & MarketingPharmaceutical

Responsible medicines use can avoid $500 billion in global health care costs, says IMS

02-10-2012

About $500 billion in global health care costs can be avoided annually through more responsible use of…

FinancialGenericsGlobalHealthcarePharmaceutical

Clinical trials due an overhaul to conquer the Pharma "Valley of Death"

30-09-2012

Costs associated with drug development have risen from around $138 million in 1975 to over $1 billion…

BiotechnologyFinancialGlobalPharmaceuticalResearch

Pharma vs the world: Big Pharma caught between investors and public

23-09-2012

Big Pharma today encounters a variety of pressures from generics manufacturers, governments, patient…

FinancialGenericsGlobalMarkets & MarketingPatentsPharmaceuticalPoliticsSanofi

A blip or stark reality? Pharma companies re-evaluate emerging markets

28-08-2012

Pharmaceutical companies, which have previously been allaying the growing fears and concerns of their…

FinancialGlobalMarkets & MarketingPharmaceuticalPricingRegulation

AstraZeneca to get $250 million-plus from OTC Nexium deal with Pfizer

15-08-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) says it has entered into an agreement with Pfizer (NYSE:…

AstraZenecaFinancialGastro-intestinalsGlobalLicensingNexiumPfizerPharmaceutical

Domestic HIV funding outpaces international investments

19-07-2012

A new report by the Joint United Nations Program on HIV/AIDS (UNAIDS) shows that domestic funding for…

Anti-viralsFinancialGlobalHealthcarePharmaceutical

Foreign efforts to lure US biopharmaceutical companies

20-05-2012

Despite increasing budget pressures, countries around the world are making substantial investments in…

BiotechnologyFinancialGlobalNorth AmericaPharmaceuticalPoliticsResearch

1 to 25 of 30 results

Back to top